[68Ga]Ga-PentixaFor-PET Imaging for Staging of Marginal Zone Lymphoma
NCT06125028
·
clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
8
Enrollment
INDUSTRY
Sponsor class
Stopped
low recruitment rate
Conditions
Marginal Zone Lymphoma
Interventions
DRUG:
[68Ga]Ga-PentixaFor
DRUG:
[18F]Fluorodeoxyglucose
Sponsor
Pentixapharm AG
Collaborators
[object Object]